Frost & Sullivan to Moderate International Conference at MEDICA 2007

Frost & SullivanHosted by the U.S. Government in partnership with Frost & Sullivan and several strategic partners, the International Conference at MEDICA 2007 is expected to see attendance by every international medical device, equipment and diagnostic company. This pioneering event offers the international medical technology community a unique opportunity to tap the expertise and resources needed to be successful on the world's most important medical market - the USA.

Dorman Followwill, Vice President, Health Care, Frost & Sullivan, who will moderate the conference, notes that this event comes at a time when international medical technology firms, facing strong cost containment pressures, slower growth and challenging regulatory environments, are looking to the U.S. as a rewarding market for innovative products.

"Clearly, the U.S. market offers medical device companies several global competitive advantages," says Followwill. "However, it is essential for international firms to implement the correct strategy on local engagement in the highly competitive U.S. market where volatile currency fluctuations, heightened scrutiny on import safety issues, complex reimbursement systems and regional/local market preferences and practices, all demand careful consideration."

Through this conference, participants will be privy to crucial information and insights aimed at helping international medtech companies establish a presence or expand in the United States. Experts from the U.S. Department of Commerce, its U.S. federal state partners, the U.S. Food and Drug Administration, along with leading industry association officials, company heads and prominent legal, financial and business advisors in the health technology sector will make presentations, participate in panel discussions.

Besides in-depth and insightful information, the forum offers attractive networking opportunities. Attendees can profit from personal consultations with expert speakers and U.S. state representatives during breaks, the relaxed networking reception and in follow on meetings.

In short, anyone responsible for a medical company's global success will find invaluable guidance and networking opportunities on November 13th at the Hilton Hotel, Düsseldorf.

About Frost & Sullivan
Frost & Sullivan, the Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit http://www.frost.com.

Most Popular Now

AI Tool Helps Predict Relapse of Pediatr…

Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns that may be missed by human observers. AI-assisted interpretation of brain scans may help improve...

Detecting Lung Cancer 4 Months Earlier a…

GPs may soon be able to identify patients with an increased risk of lung cancer up to 4 months earlier than is currently the case. The GP should be able...

Infectious Disease Surveillance Platform…

The Biothreats Emergence, Analysis and Communications Network (BEACON) leverages advanced artificial intelligence (AI), large language models (LLMs) and a network of globally based experts to rapidly collect, analyze, and disseminate...

Children's Health Ireland to Transf…

Healthcare teams responsible for paediatric care in Ireland are to save significant time in accessing important diagnostic imaging and reports, with the help of a new agreement with medical imaging...

NHS, Councils, and Housing could Share N…

A new technology partnership formally announced, could help NHS, local government, and housing organisations collaborate to create an unprecedented understanding of the risks and needs of people in their care...

AI-Powered Analysis of Stent Healing

Each year, more than three million people worldwide are treated with stents to open blocked blood vessels caused by heart disease. However, monitoring the healing process after implantation remains a...

Right Patient, Right Dose, Right Time

While artificial intelligence (AI) has shown promising potential, much of its use has remained theoretical or retrospective. Turning its potential into real-world healthcare outcomes, researchers at the Yong Loo Lin...

An AI Tool Grounded in Evidence-Based Me…

A powerful clinical artificial intelligence tool developed by University at Buffalo biomedical informatics researchers has demonstrated remarkable accuracy on all three parts of the United States Medical Licensing Exam (Step...

AXREM and BHTA Name Highland as 'Fu…

Hosted by trade associations AXREM and the British Healthcare Trades Association (BHTA), 'The Future of MedTech - Innovating for Tomorrow', will allow delegates to engage with speakers from the government...